Quantcast
Channel: Health Canada RSS - Prescription Drug List
Browsing index pages (140 articles)

Notice: Multiple additions to the Prescription Drug List (PDL) [2026-08-27]

Document to announce multiple updates to the Prescription Drug List.

View Article


Information about the Prescription Drug List: Notice

Health Canada is pleased to announce the publication of new web pages: Overview of the Prescription Drug List and Processes to Amend the Prescription Drug List. Together these pages are replacing the...

View Article


Notice: Multiple additions to the Prescription Drug List (PDL) [2026-06-25]

Document to announce multiple updates to the Prescription Drug List.

View Article

Health Canada has changed the Prescription Drug List qualifier related to...

Document to announce an amendment to the qualifier for melatonin on the Prescription Drug List.

View Article

Glucagon for injection supply in Canada: Notice [2026-05-29]

Glucagon for injection is used for the emergency treatment of severe hypoglycemia (low blood sugar). Beginning in May 2023, we allowed Amphastar Pharmaceuticals Inc. to import US-authorized Glucagon...

View Article


Health Canada is changing the Prescription Drug List qualifier related to...

Document to announce Health Canada’s intent to revise the qualifier for melatonin on the Prescription Drug List.

View Article

Notice of consultation: Proposed change to the veterinary omeprazole listing...

Document to announce a consultation on the proposal to change the veterinary omeprazole listing on the Prescription Drug List (PDL).

View Article

Notice: Multiple additions to the Prescription Drug List (PDL) [2026-04-30]

Document to announce multiple updates to the Prescription Drug List.

View Article


Phenytoin sodium capsules and phenytoin chewable tablets in short supply: Notice

Phenytoin sodium capsules and phenytoin chewable tablets are used to control seizures. Supply constraints could impact the availability of these drugs in Canada until early May 2026.

View Article


Pharmaceutical and Life Sciences Sector Task Force

The Pharmaceutical and Life Sciences Sector Task Force is a joint federal initiative led by Health Canada and Innovation, Science and Economic Development Canada. The task force will support reliable...

View Article

Notice: Multiple additions to the Prescription Drug List (PDL) [2026-02-26]

Documents to announce multiple updates to the Prescription Drug List.

View Article

Notice of consultation: Removing zuranolone from the Prescription Drug List...

Document to announce a consultation on the proposal to remove zuranolone from the Prescription Drug List (PDL).

View Article

Health product shortages in Canada: Fiscal year 2024 to 2025 in review

An overview of drug and medical device shortages in Canada for the 2024 to 2025 fiscal year.

View Article


Notice of amendment: Revisions to the Prescription Drug List for nicotine...

Documents to announce that Health Canada has revised the qualifier of the “Nicotine or its salts” listing on the human use part of the Prescription Drug List (PDL).

View Article

Consultation: Draft guidance on decentralized clinical trials

Health Canada has drafted a guidance document on decentralized clinical trials. The draft guidance outlines regulatory considerations and practical strategies for conducting clinical trials with...

View Article


Consultation: Modernizing the framework for clinical trials

Health Canada is seeking feedback on the proposed Clinical Trials Regulations for drugs (pharmaceuticals, biologics and radiopharmaceuticals) and on multiple guidance documents related to the proposal.

View Article

Notice: Multiple Additions to the Prescription Drug List (PDL)

Documents to announce multiple updates to the Prescription Drug List.

View Article


Consultation: Adding melatonin for sleep-related use in the pediatric...

Document to announce the proposal to revise the qualifier for melatonin on the Prescription Drug List.

View Article

Notice of amendment: Addition of melatonin to the Prescription Drug List

The purpose of this Notice of Amendment is to announce the addition of "melatonin or its salts” to the human use part of the Prescription Drug List (PDL). This addition will not be made to the...

View Article

Health Canada and the Public Health Agency of Canada’s report on red tape...

Health Canada and the Public Health Agency of Canada have conducted a broad review of regulations and program administration to identify outdated, inefficient or duplicate regulations that hinder...

View Article
Browsing index pages (140 articles)


Latest Images